This focused review, checked again on 22 October 2026, did not identify a randomised traveller trial establishing one best antiseizure medicine schedule for all time zones. This is a focused resource review, not a systematic review. Practical travel recommendations therefore combine adherence principles, drug-specific pharmacology and individual clinical judgement.
A 2023 pharmacokinetic simulation study examined delayed or missed doses of 11 antiseizure medicines. The modelled best response varied with delay, dose interval, drug half-life and patient factors. It did not test a jet-lag travel schedule or prove a clinical benefit from patients changing doses themselves.
Chronotherapy means tailoring treatment to seizure rhythms. A 2011 retrospective series of 17 children with night-time or early-morning seizures reported benefit from proportionally higher evening dosing. It involved selected children, not people crossing time zones. A January 2026 computational study also suggested timing could matter, especially for shorter-half-life medicines, but requires clinical validation.
A small 2006 observational study of 37 travellers found increased seizures after flying in some participants, particularly those with higher baseline seizure frequency or previous flight-related increases. It cannot isolate jet lag from sleep loss, stress or other travel factors, or tell us which dose-transition schedule works best.
- Practical conclusion: preserve reliable dosing and sleep while arranging a personalised transition.
- A universal rule such as “shift every medicine by 30 minutes each day”, “take an extra half dose”, or “make the evening dose larger” is not established by these studies.
- Do not use a chronotherapy paper or a missed-dose model as a self-prescribing travel calculator.
Supporting source ↗ · Supporting source ↗ · Supporting source ↗ · Supporting source ↗